Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions.
Shen GH, Tsao TC, Kao SJ, Lee JJ, Chen YH, Hsieh WC, Hsu GJ, Hsu YT, Huang CT, Lau YJ, Tsao SM, Hsueh PR.
Int J Antimicrob Agents. 2012 Mar;39(3):201-5. Epub 2012 Jan 28.
Related citations
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
Apisarnthanarak A, Mundy LM.
Int J Antimicrob Agents. 2012 Mar;39(3):271-2. Epub 2012 Jan 10. No abstract available.
Mechanism of resistance of a highly carbapenem-resistant Klebsiella oxytoca isolate and comparison of susceptibility to five carbapenems.
Sho T, Muratani T, Mizokami Y, Hamasuna R, Fujimoto N, Matsumoto T.
Int J Antimicrob Agents. 2012 Mar;39(3):268-9. Epub 2012 Jan 5. No abstract available.
Molecular characterisation of high-level gentamicin-resistant enterococci from bloodstream infections in Denmark: first description of clonal spread of aph(2'')-Ib.
Hammerum AM, Lester CH, Olsen SS, Holm A, Hansen DS, Schønheyder HC.
Int J Antimicrob Agents. 2012 Mar;39(3):266-8. Epub 2012 Jan 5. No abstract available.
Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.
Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, Gérard M, Verbruggen AM, Deplano A, Denis O, Bogaerts P.
Int J Antimicrob Agents. 2012 Feb;39(2):168-72. Epub 2011 Nov 23.
Molecular characterisation of high-level ciprofloxacin-resistant Salmonella enterica with multiple antibiotic resistance and class 1 integrons isolated from imported foods.
Akiyama T, Khan AA, Nawaz MS, West CS.
Int J Antimicrob Agents. 2012 Mar;39(3):263-4. Epub 2011 Nov 17. No abstract available.
Community-onset bacteraemia caused by fluoroquinolone-resistant Klebsiella pneumoniae: clinical epidemiology and risk factors.
Kang CI, Lee JA, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.
Int J Antimicrob Agents. 2012 Feb;39(2):181-2. Epub 2011 Nov 17. No abstract available.
In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae.
Fukuda Y, Takahata M, Sugiura Y, Shinmura Y, Nomura N.
Int J Antimicrob Agents. 2012 Feb;39(2):163-7. Epub 2011 Nov 15.
Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
Shu JC, Chia JH, Siu LK, Kuo AJ, Huang SH, Su LH, Wu TL.
Int J Antimicrob Agents. 2012 Mar;39(3):217-22. Epub 2011 Nov 10.
Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.
Little ML, Qin X, Zerr DM, Weissman SJ.
Int J Antimicrob Agents. 2012 Jan;39(1):52-7. Epub 2011 Nov 3.
Silver resistance: an alarming public health concern?
Jakobsen L, Andersen AS, Friis-Møller A, Jørgensen B, Krogfelt KA, Frimodt-Møller N.
Int J Antimicrob Agents. 2011 Nov;38(5):454-5. Epub 2011 Sep 3. No abstract available.
Pseudomonas aeruginosa and carbapenems: the urgent need to harmonise disagreeing breakpoints.
Gómez-Garcés JL, López-Fabal F, Burillo A, Gil Y.
Int J Antimicrob Agents. 2011 Nov;38(5):452-3. Epub 2011 Sep 1. No abstract available.
Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
Wang H, Chen M, Xu Y, Sun H, Yang Q, Hu Y, Cao B, Chu Y, Liu Y, Zhang R, Yu Y, Sun Z, Zhuo C, Ni Y, Hu B, Tan TY, Hsueh PR, Wang JH, Ko WC, Chen YH, Wahjono H.
Int J Antimicrob Agents. 2011 Nov;38(5):376-83. Epub 2011 Aug 30.
Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa.
Ruiz-Martínez L, López-Jiménez L, Fusté E, Vinuesa T, Martínez JP, Viñas M.
Int J Antimicrob Agents. 2011 Nov;38(5):398-402. Epub 2011 Aug 27.
In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
Mitsugui CS, Tognim MC, Cardoso CL, Carrara-Marroni FE, Botelho Garcia L.
Int J Antimicrob Agents. 2011 Nov;38(5):447-50. Epub 2011 Aug 26.
Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.
Int J Antimicrob Agents. 2011 Nov;38(5):403-8. Epub 2011 Aug 26.
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
Alcazar-Fuoli L, Cuesta I, Rodriguez-Tudela JL, Cuenca-Estrella M, Sanglard D, Mellado E.
Int J Antimicrob Agents. 2011 Nov;38(5):426-34. Epub 2011 Aug 25.
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
Patel D, Husain M, Vidaillac C, Steed ME, Rybak MJ, Seo SM, Kaatz GW.
Int J Antimicrob Agents. 2011 Nov;38(5):442-6. Epub 2011 Aug 12.
Molecular characterisation of multidrug-resistant Salmonella enterica serotype Infantis from humans, animals and the environment in Italy.
Dionisi AM, Lucarelli C, Benedetti I, Owczarek S, Luzzi I.
Int J Antimicrob Agents. 2011 Nov;38(5):384-9. Epub 2011 Aug 6.
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK, Jung SI, Park KH, Kim SH, Ko KS.
Int J Antimicrob Agents. 2012 Jan;39(1):81-5. Epub 2011 Oct 12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on